## KMX: CarMax Inc - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 0.64 indicates fundamental undervaluation. Caution: declining volume (55% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($36.10)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Pomerantz LLP Issues Important Reminder to Investors in CarMax, Inc. of Class Action – KMX**
- Source: SiouxlandProud | 20251206T002243 | Neutral | Relevance: 99%
-  Pomerantz LLP has issued an important reminder to investors in CarMax, Inc. regarding a class action lawsuit filed against the company for alleged securities fraud or other unlawful business practices. Investors who purchased CarMax securities during the Class Period are encouraged to contact the firm to ask the Court to appoint them as Lead Plaintiff by January 2, 2026. This action follows CarMax's Q2 2026 fiscal year results, which reported earnings and sales significantly below consensus estimates, causing a 20.07% drop in the stock price.

**2. CARMAX, INC. (NYSE: KMX) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds CarMax, Inc. Investors of Upcoming Deadline**
- Source: CBS 42 | 20251208T151409 | Neutral | Relevance: 99%
-  Bernstein Liebhard LLP has issued a shareholder alert for investors of CarMax, Inc. (NYSE: KMX) regarding an upcoming deadline in a securities fraud class action lawsuit. The lawsuit alleges that CarMax made misrepresentations concerning its growth prospects, impacting investors who purchased shares between June 20, 2025, and November 5, 2025. Investors have until January 2, 2026, to file papers to serve as lead plaintiff.

**3. Investors Urged to Contact Levi & Korsinsky for Information Before January 2, 2026 - CarMax, Inc. (KMX)**
- Source: WRBL | 20251207T113100 | Neutral | Relevance: 99%
-  Levi & Korsinsky, LLP urges investors who suffered losses in CarMax, Inc. (NYSE: KMX) between June 20, 2025, and November 5, 2025, to contact the firm for a potential recovery under federal securities laws. A class action lawsuit alleges CarMax overstated growth prospects, benefiting temporarily from customers buying cars due to tariff speculation. Shareholders are encouraged to visit zlk.com for more information regarding their rights.

**4. KMX Stockholders with Large Losses Should Contact Robbins**
- Source: GlobeNewswire | 20251208T181409 | Neutral | Relevance: 99%
-  Robbins LLP is reminding CarMax, Inc. (NYSE: KMX) stockholders who experienced losses from June 20, 2025, to September 24, 2025, about a securities class action lawsuit against the company. The lawsuit alleges CarMax misled investors regarding its 2026 growth prospects, which were temporary gains due to tariff speculation, leading to a significant stock price drop on September 25, 2025. Stockholders have until January 2, 2026, to file as lead plaintiff.

**5. CarMax, Inc. (KMX) Lawsuit – Investors Urged to Contact Levi & Korsinsky Before January 2, 2026**
- Source: ConchoValleyHomepage.com | 20251207T000910 | Neutral | Relevance: 99%
- A class action securities lawsuit has been filed against CarMax, Inc. (NYSE:KMX), alleging that the company overstated its growth prospects, leading to investor losses. Shareholders who suffered losses between June 20, 2025, and November 5, 2025, are encouraged to contact Levi & Korsinsky LLP to learn about their rights before January 2, 2026. The lawsuit claims that CarMax's earlier fiscal year growth was only a temporary benefit from tariff speculation.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | Wedbush | $40 | $40 | 0% |
| 2025-11-12 | Barclays | $28 | $0 | 0% |
| 2025-11-10 | Morgan Stanley | $35 | $56 | -38% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | Wedbush | reit | Neutral |
| 2025-11-12 | Barclays | init | Underweight |
| 2025-11-10 | Morgan Stanley | down | Equal-Weight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.5% (-3.8%)
- Blackrock Inc.: 7.8% (+5.9%)
- State Street Corpora: 3.8% (-2.2%)
- Janus Henderson Grou: 3.3% (+1.0%)
- Diamond Hill Capital: 3.3% (-30.6%)

### Key Risks

1. Elevated short interest (11.4%): bears positioning against stock.
2. Long-term trend broken: trading 34.0% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.64 indicates undervaluation relative to growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (1 target cuts vs 0 raises). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.9B |
| Beta | 1.29 |
| 52W Range | $30.26 - $91.25 |
| Short Interest | 11.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.64 |
| Forward P/E | 13.5 |
| Current P/E | 15.1 |
| YoY Growth | 12.0% |
| EPS Direction | FALLING |

### Technicals

MRS_20 stable at 6.5% (minimal 5-day change). Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 88th percentile. MRS_5 at 0.6% confirms short-term momentum alignment. AM_20 at 8.6% shows strong absolute momentum above own 20MA. Outperforming sector by 7.3pp, stock-specific strength. Below SMA200 (0.66x), long-term trend not supportive. MACD histogram positive (0.84), confirming momentum. RSI neutral at 54. Volume at 55% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.48% (CS: 89) | Strong |
| RSI_14 | 54.1 | Neutral |
| MACD Histogram | 0.84 | Bullish |
| vs SMA20 | 1.086x | Above |
| vs SMA50 | 0.975x | Below |
| vs SMA200 | 0.660x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $39.26
- **Stop Loss:** $36.10 (8.0% risk)
- **Target:** $45.58 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 158
- **Position Value:** $6,203.08
- **Portfolio %:** 6.20%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2025-12-18 (Est: $0.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |
| 2024Q4 | $0.61 | $0.81 | +33.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*